• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与脂溶性化合物偶联的反义寡核苷酸:杜氏肌营养不良症外显子跳跃的合成与体外评价。

Antisense Oligonucleotides Conjugated with Lipophilic Compounds: Synthesis and In Vitro Evaluation of Exon Skipping in Duchenne Muscular Dystrophy.

机构信息

Department of Environmental and Prevention Sciences, University of Ferrara, 44121 Ferrara, Italy.

Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, 44121 Ferrara, Italy.

出版信息

Int J Mol Sci. 2022 Apr 12;23(8):4270. doi: 10.3390/ijms23084270.

DOI:10.3390/ijms23084270
PMID:35457088
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9032562/
Abstract

Our groups previously reported that conjugation at 3'-end with ursodeoxycholic acid (UDCA) significantly enhanced in vitro exon skipping properties of ASO 51 oligonucleotide targeting the human DMD exon 51. In this study, we designed a series of lipophilic conjugates of ASO 51, to explore the influence of the lipophilic moiety on exon skipping efficiency. To this end, three bile acids and two fatty acids have been derivatized and/or modified and conjugated to ASO 51 by automatized solid phase synthesis. We measured the melting temperature () of lipophilic conjugates to evaluate their ability to form a stable duplex with the target RNA. The exon skipping efficiency has been evaluated in myogenic cell lines first in presence of a transfection agent, then in gymnotic conditions on a selection of conjugated ASO 51. In the case of 5'-UDC-ASO 51, we also evaluated the influence of PS content on exon skipping efficiency; we found that it performed better exon skipping with full PS linkages. The more efficient compounds in terms of exon skipping were found to be 5'-UDC- and 5',3'-bis-UDC-ASO 51.

摘要

我们的团队之前曾报道过,在 3'末端与熊去氧胆酸(UDCA)缀合可显著增强针对人类 DMD 外显子 51 的 ASO 51 寡核苷酸的体外外显子跳跃特性。在这项研究中,我们设计了一系列 ASO 51 的亲脂性缀合物,以探索亲脂部分对外显子跳跃效率的影响。为此,我们对三种胆酸和两种脂肪酸进行了衍生化和/或修饰,并通过自动化固相合成将其与 ASO 51 缀合。我们测量了亲脂性缀合物的熔点(),以评估其与靶 RNA 形成稳定双链的能力。首先在转染剂存在的情况下,在肌源性细胞系中评估了外显子跳跃效率,然后在选择的缀合 ASO 51 上在非电转条件下进行评估。在 5'-UDC-ASO 51 的情况下,我们还评估了 PS 含量对外显子跳跃效率的影响;我们发现,它具有完整 PS 键合的更好的外显子跳跃性能。在提高外显子跳跃效率方面,更有效的化合物是 5'-UDC-和 5',3'-双 UDC-ASO 51。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/e246a8409610/ijms-23-04270-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/7f16e9621e74/ijms-23-04270-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/b11b6260162b/ijms-23-04270-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/01a987278642/ijms-23-04270-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/325c8ecea1a4/ijms-23-04270-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/353368e285e4/ijms-23-04270-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/94ad190f245c/ijms-23-04270-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/1a01c2d6afc0/ijms-23-04270-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/4c697b2bd81d/ijms-23-04270-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/a5523907cf23/ijms-23-04270-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/6bcf6e81605b/ijms-23-04270-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/e246a8409610/ijms-23-04270-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/7f16e9621e74/ijms-23-04270-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/b11b6260162b/ijms-23-04270-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/01a987278642/ijms-23-04270-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/325c8ecea1a4/ijms-23-04270-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/353368e285e4/ijms-23-04270-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/94ad190f245c/ijms-23-04270-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/1a01c2d6afc0/ijms-23-04270-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/4c697b2bd81d/ijms-23-04270-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/a5523907cf23/ijms-23-04270-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/6bcf6e81605b/ijms-23-04270-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e49/9032562/e246a8409610/ijms-23-04270-g007.jpg

相似文献

1
Antisense Oligonucleotides Conjugated with Lipophilic Compounds: Synthesis and In Vitro Evaluation of Exon Skipping in Duchenne Muscular Dystrophy.与脂溶性化合物偶联的反义寡核苷酸:杜氏肌营养不良症外显子跳跃的合成与体外评价。
Int J Mol Sci. 2022 Apr 12;23(8):4270. doi: 10.3390/ijms23084270.
2
Synthesis and Exon-Skipping Properties of a 3'-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach.3′-熊去氧胆酸偶联寡核苷酸靶向前体 mRNA 的合成及外显子跳跃性质:前合成与后合成方法。
Molecules. 2021 Dec 17;26(24):7662. doi: 10.3390/molecules26247662.
3
In vitro evaluation of novel antisense oligonucleotides is predictive of in vivo exon skipping activity for Duchenne muscular dystrophy.新型反义寡核苷酸的体外评估可预测杜氏肌营养不良症的体内外显子跳跃活性。
J Gene Med. 2010 Apr;12(4):354-64. doi: 10.1002/jgm.1446.
4
Designing Effective Antisense Oligonucleotides for Exon Skipping.设计用于外显子跳跃的有效反义寡核苷酸
Methods Mol Biol. 2018;1687:143-155. doi: 10.1007/978-1-4939-7374-3_10.
5
Levels of Exon-Skipping Are Not Artificially Overestimated Because of the Increased Affinity of Tricyclo-DNA-Modified Antisense Oligonucleotides to the Target Exon.外显子跳跃水平不会因三环 DNA 修饰的反义寡核苷酸与目标外显子的亲和力增加而被人为高估。
Nucleic Acid Ther. 2024 Oct;34(5):214-220. doi: 10.1089/nat.2024.0002. Epub 2024 Jul 24.
6
Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression.将人类杜氏肌营养不良症(DMD)成纤维细胞直接重编程为肌管,用于体外评估反义介导的外显子跳跃以及外显子45 - 55跳跃并伴有肌营养不良蛋白表达恢复的情况。
Methods Mol Biol. 2018;1828:141-150. doi: 10.1007/978-1-4939-8651-4_8.
7
In Vitro Multiexon Skipping by Antisense PMOs in Dystrophic Dog and Exon 7-Deleted DMD Patient.反义磷酰二胺吗啉代寡聚物(PMO)在营养不良犬和7号外显子缺失的杜氏肌营养不良症(DMD)患者中诱导的体外多外显子跳跃
Methods Mol Biol. 2018;1828:151-163. doi: 10.1007/978-1-4939-8651-4_9.
8
Nonclinical Exon Skipping Studies with 2'-O-Methyl Phosphorothioate Antisense Oligonucleotides in mdx and mdx-utrn-/- Mice Inspired by Clinical Trial Results.基于临床试验结果的 2'-O-甲基硫代磷酸酯反义寡核苷酸在 mdx 和 mdx-utrn-/- 小鼠中非临床外显子跳跃研究。
Nucleic Acid Ther. 2019 Apr;29(2):92-103. doi: 10.1089/nat.2018.0759. Epub 2019 Jan 23.
9
In vivo comparison of 2'-O-methyl phosphorothioate and morpholino antisense oligonucleotides for Duchenne muscular dystrophy exon skipping.2'-O-甲基硫代磷酸酯和吗啉代反义寡核苷酸用于杜氏肌营养不良症外显子跳跃的体内比较。
J Gene Med. 2009 Mar;11(3):257-66. doi: 10.1002/jgm.1288.
10
Phosphorothioate modification of chimeric 2´-O-methyl RNA/ethylene-bridged nucleic acid oligonucleotides increases dystrophin exon 45 skipping capability and reduces cytotoxicity.嵌合2'-O-甲基RNA/乙烯桥连核酸寡核苷酸的硫代磷酸酯修饰增强了肌营养不良蛋白外显子45跳跃能力并降低了细胞毒性。
Kobe J Med Sci. 2015 Feb 17;60(4):E86-94.

引用本文的文献

1
Enhancing G-quadruplex-based DNA nanotechnology: new lipophilic DNA G-quadruplexes with TBDPS modifications.增强基于G-四链体的DNA纳米技术:具有叔丁基二苯基硅烷基修饰的新型亲脂性DNA G-四链体
RSC Adv. 2025 May 29;15(23):17933-17945. doi: 10.1039/d5ra01033k.
2
Clinical applications of exon-skipping antisense oligonucleotides in neuromuscular diseases.外显子跳跃反义寡核苷酸在神经肌肉疾病中的临床应用
Mol Ther. 2025 Jun 4;33(6):2689-2704. doi: 10.1016/j.ymthe.2025.04.038. Epub 2025 Apr 30.
3
In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment.

本文引用的文献

1
Control of backbone chemistry and chirality boost oligonucleotide splice switching activity.控制主链化学和手性可增强寡核苷酸剪接切换活性。
Nucleic Acids Res. 2022 Jun 10;50(10):5443-5466. doi: 10.1093/nar/gkac018.
2
Synthesis and Exon-Skipping Properties of a 3'-Ursodeoxycholic Acid-Conjugated Oligonucleotide Targeting Pre-mRNA: Pre-Synthetic versus Post-Synthetic Approach.3′-熊去氧胆酸偶联寡核苷酸靶向前体 mRNA 的合成及外显子跳跃性质:前合成与后合成方法。
Molecules. 2021 Dec 17;26(24):7662. doi: 10.3390/molecules26247662.
3
Palmitic acid conjugation enhances potency of tricyclo-DNA splice switching oligonucleotides.
评估用于杜氏肌营养不良症治疗的熊去氧胆酸共轭寡核苷酸肠道渗透性的体外研究
Pharmaceutics. 2024 Aug 1;16(8):1023. doi: 10.3390/pharmaceutics16081023.
4
Self-Penetrating Oligonucleotide Derivatives: Features of Self-Assembly and Interactions with Serum and Intracellular Proteins.自穿透寡核苷酸衍生物:自组装特征及其与血清和细胞内蛋白质的相互作用
Pharmaceutics. 2023 Dec 14;15(12):2779. doi: 10.3390/pharmaceutics15122779.
5
Fork- and Comb-like Lipophilic Structures: Different Chemical Approaches to the Synthesis of Oligonucleotides with Multiple Dodecyl Residues.叉状和梳状亲脂结构:用多种十二烷基残基合成寡核苷酸的不同化学方法。
Int J Mol Sci. 2023 Sep 27;24(19):14637. doi: 10.3390/ijms241914637.
6
Lipid and Peptide-Oligonucleotide Conjugates for Therapeutic Purposes: From Simple Hybrids to Complex Multifunctional Assemblies.用于治疗目的的脂质与肽 - 寡核苷酸缀合物:从简单杂合体到复杂多功能组装体
Pharmaceutics. 2023 Jan 18;15(2):320. doi: 10.3390/pharmaceutics15020320.
软脂酸缀合可增强三环 DNA 剪接寡核苷酸的效力。
Nucleic Acids Res. 2022 Jan 11;50(1):17-34. doi: 10.1093/nar/gkab1199.
4
Renadirsen, a Novel 2'OMeRNA/ENA Chimera Antisense Oligonucleotide, Induces Robust Exon 45 Skipping for Dystrophin In Vivo.Renadirsen,一种新型 2'OMeRNA/ENA 嵌合反义寡核苷酸,在体内诱导肌营养不良蛋白外显子 45 的有效跳跃。
Curr Issues Mol Biol. 2021 Sep 25;43(3):1267-1281. doi: 10.3390/cimb43030090.
5
RNA-Targeting Splicing Modifiers: Drug Development and Screening Assays.RNA 靶向剪接调节剂:药物研发和筛选检测。
Molecules. 2021 Apr 14;26(8):2263. doi: 10.3390/molecules26082263.
6
Delivery of oligonucleotide-based therapeutics: challenges and opportunities.寡核苷酸类治疗药物的递送:挑战与机遇。
EMBO Mol Med. 2021 Apr 9;13(4):e13243. doi: 10.15252/emmm.202013243. Epub 2021 Apr 6.
7
Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing.通过剪接调控和基因编辑实现杜氏肌营养不良症的分子矫正。
RNA Biol. 2021 Jul;18(7):1048-1062. doi: 10.1080/15476286.2021.1874161. Epub 2021 Jan 20.
8
Restorative treatments of dystrophin expression in Duchenne muscular dystrophy: A systematic review.杜氏肌营养不良症中肌营养不良蛋白表达的修复治疗:系统评价。
Ann Clin Transl Neurol. 2020 Sep;7(9):1738-1752. doi: 10.1002/acn3.51149. Epub 2020 Aug 10.
9
Advances in oligonucleotide drug delivery.寡核苷酸药物递送的进展。
Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11.
10
Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update.杜氏肌营养不良症的治疗策略:最新进展。
Genes (Basel). 2020 Jul 23;11(8):837. doi: 10.3390/genes11080837.